
Validation of Noninvasive Diagnosis of BK Virus Nephropathy and Identification of Prognostic Biomarkers
Author(s) -
Darshana Dadhania,
Catherine Snopkowski,
Ruchuang Ding,
Thangamani Muthukumar,
Jun Lee,
Heejung Bang,
Vijay Kumar Sharma,
Surya V. Seshan,
Phyllis August,
Sandip Kapur,
Manikkam Suthanthiran
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3181e2a932
Subject(s) - medicine , nephropathy , renal function , biopsy , urinary system , urology , gastroenterology , endocrinology , diabetes mellitus
BK virus nephropathy (BKVN) may cause renal allograft dysfunction and failure. The gold standard test is kidney biopsy, which is invasive and costly. A noninvasive, accurate biomarker for diagnosis of BKVN and prognostication of allograft function after BKVN infection may improve allograft survival.